However, given the extraordinarily high prevalence of Ras pathway activation in human tumors, including Schwann cell-derived tumors, e.g., neurofibromas caused by loss of NF1 [4], regulation of Ras signaling very likely contributes significantly to merlin’s tumor suppressor activity. The gene discussed is NF2; the disease is plexiform neurofibroma.